Documents
Application Sponsors
| NDA 020065 | BAUSCH AND LOMB |  | 
Marketing Status
Application Products
| 001 | SOLUTION/DROPS;OPHTHALMIC | 0.02675%;0.315% | 1 | OPCON-A | NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE | 
FDA Submissions
| TYPE 5; Type 5 - New Formulation or New Manufacturer | ORIG | 1 | AP | 1994-06-08 | STANDARD | 
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 2 | AP | 1994-11-29 | STANDARD | 
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 3 | AP | 1994-11-29 | STANDARD | 
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 5 | AP | 1995-05-11 | STANDARD | 
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 8 | AP | 1996-04-11 | STANDARD | 
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 9 | AP | 1996-03-13 | STANDARD | 
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 10 | AP | 2005-04-20 | STANDARD | 
| LABELING; Labeling | SUPPL | 11 | AP | 1996-05-09 | STANDARD | 
| LABELING; Labeling | SUPPL | 13 | AP | 1996-07-23 | STANDARD | 
| LABELING; Labeling | SUPPL | 14 | AP | 1996-07-23 | STANDARD | 
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 15 | AP | 1996-12-18 | STANDARD | 
| LABELING; Labeling | SUPPL | 17 | AP | 2007-07-31 | STANDARD | 
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 20 | AP | 2015-05-12 | STANDARD | 
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 21 | AP | 2015-09-18 | STANDARD | 
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 22 | AP | 2016-03-14 | STANDARD | 
| LABELING; Labeling | SUPPL | 33 | AP | 2022-09-23 | STANDARD | 
Submissions Property Types
| SUPPL | 1 | Null | 0 | 
| SUPPL | 2 | Null | 0 | 
| SUPPL | 3 | Null | 0 | 
| SUPPL | 5 | Null | 0 | 
| SUPPL | 8 | Null | 0 | 
| SUPPL | 9 | Null | 0 | 
| SUPPL | 10 | Null | 0 | 
| SUPPL | 15 | Null | 0 | 
| SUPPL | 20 | Null | 0 | 
| SUPPL | 21 | Null | 0 | 
| SUPPL | 22 | Null | 0 | 
| SUPPL | 33 | Null | 31 | 
CDER Filings
BAUSCH AND LOMB
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20065
            [companyName] => BAUSCH AND LOMB
            [docInserts] => ["",""]
            [products] => [{"drugName":"OPCON-A","activeIngredients":"NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE","strength":"0.02675%;0.315%","dosageForm":"SOLUTION\/DROPS;OPHTHALMIC","marketingStatus":"Over-the-counter","te":"None","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"07\/31\/2007","submission":"SUPPL-17","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/020065s017lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"OPCON-A","submission":"NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE","actionType":"0.02675%;0.315%","submissionClassification":"SOLUTION\/DROPS;OPHTHALMIC","reviewPriority":"Over-the-counter","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2007-07-31
        )
)